首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Cancer Reports

Cancer Reports杂志,由Wiley出版,于2018年创刊,Monthly,出版语言English,ISSN:2573-8348。

投稿咨询
Cancer Reports
Cancer Reports
Cancer Reports
SCIE

杂志介绍

JCR分区
Q3
中科院分区
4区
影响因子
2.5
CiteScore
3.7
期刊收录
SCIE

Cancer Reports(中文译名:《癌症报告》),ISSN:2573-8348,是Wiley出版的国际性学术期刊,创刊于2018年,以Monthly形式稳定发行,2026年总发文量约322篇。该刊采用非OA开放访问,学科归属为Medicine - Oncology。该刊是医学、肿瘤学领域的国际权威刊物,已被SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.5,2025年期刊CiteScore为3.7,2025年期刊自引率约4%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Cancer Reports长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期17 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAIndia、Australia、Japan、CHINA MAINLAND、England、Italy等为核心发文国家与地区;TATA MEMORIAL CENTRE (TMC)ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS) NEW DELHI、UNIVERSITY OF SYDNEY、UNIVERSITY OF TEXAS SYSTEM、ALL INDIA INSTITUTE OF MEDICAL SCIENCES (AIIMS) RISHIKESH、HOMI BHABHA NATIONAL INSTITUTE、INDIAN INSTITUTE OF TECHNOLOGY SYSTEM (IIT SYSTEM)等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
ONCOLOGY 肿瘤学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q3 204 / 333

38.9

学科:ONCOLOGY ESCI Q4 260 / 333

22.07

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q4 259 / 322

19.7

学科:ONCOLOGY ESCI Q4 268 / 322

16.93


中国学者近期发文

1
Alpha-Fetoprotein Is a Potential Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC): A Case Repor

Author:Zhong, Kaiwen; Wu, Xiaoying; Lin, Xiangling; Xie, Maoyun; Deng, Min; Tao, Qiang; Qin, Wei; Peng, Songlin

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70547

2
Application of Digital Medicine to the Diagnosis and Treatment of Head and Neck Tumor

Author:He, Bin; Hu, Yanghao; Wang, Zhikai; Tong, Yejingwen; Gan, Shengqi; Zhu, Yaojie; Wang, Chongyang; Ye, Dong

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70556

3
Comprehensive Bioinformatic Analysis of TONSL Expression in Pan-Cance

Author:Yang, Ying; Zhou, Bolan

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70551

4
NFIB Regulates Chemoresistance in Small Cell Lung Cancer by Suppressing Notch Signaling Activit

Author:Qin, Weixin; Wang, Ziyan; Deng, Shuzhe; Qiu, Huilei; Meng, Hongxue; Geng, Jingshu

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70526

5
CHI3L1 Is Associated With TP53 Signaling and Promotes Papillary Thyroid Carcinoma Progressio

Author:Cai, Fen; Zhou, Ya'nan; Yang, Yeran; Zhang, Meng; Zhang, Xuan; Chang, Yan; Wang, Shengcai; Wu, Xinyuan; Guo, Yongli; Yu, Yongbo; Ni, Xin; Geng, Jiangqiao

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70553

6
PRKD3 Overexpression May Improve Survival and Suppresses Proliferation in Colorectal Cance

Author:Zhang, Bin; Chang, Chen; Chen, Jingli; Cao, Yue; Chang, Yu; Liu, Lele; Li, Wensheng; Wang, Guorong

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70543

7
Effect of First-Line Chemotherapy Alone Versus First-Line Chemotherapy Plus Radiotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer in the IMRT Era: A Retrospective Cohort Stud

Author:Liu, Zihao; Tian, Yaru; Ma, Ji; Meng, Dong-Fang

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 4, pp. -. DOI: 10.1002/cnr2.70531

8
Setup Error Differences and Margin Expansion Among Rectal Cancer Segments: Consistency Evaluation Between EPID and iSCOU

Author:Wan, Bao; Han, Jiangtao; Wu, Qian; Lu, Jingjing; Li, Xueshan; Zheng, Yongtai; Liu, Chao; Sun, Shuo; Zhao, Yu; Huan, Fukui; Li, Tantan

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 3, pp. -. DOI: 10.1002/cnr2.70515

9
The Aberrant Activation of NLRP3 in Microsatellites Stability Colon Cancer Promotes M2 Macrophage Polarization Based on the TCGA Database and Tissue Microarray Analysi

Author:Lu, Li; Wu, Menglin; Jiang, Xunzhen; Liu, Tong; Fu, Weihua; Li, Weidong; Li, Xue; Zhao, Zhicheng

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 3, pp. -. DOI: 10.1002/cnr2.70470

10
Expanding the Anatomical Distribution of PRRX1::KMT2D Fusion Mesenchymal Neoplasms: A Rare Mediastinal Case Repor

Author:Zhong, Weixiang; Deng, Yu; Sun, Ke

Journal: CANCER REPORTS. 2026; Vol. 9, Issue 3, pp. -. DOI: 10.1002/cnr2.70516


在线咨询

Cancer Reports

国际简称:Cancer Rep-Us参考译名:癌症报告

年发文量:322 CiteScore:3.7 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:86.65%
Cancer Reports